Amicus Therapeutics Appoints Simon Harford As Chief Financial Officer Effective Immediately; Daphne Quimi To Retire At Year End
Portfolio Pulse from Benzinga Newsdesk
Amicus Therapeutics has appointed Simon Harford as its new Chief Financial Officer, effective immediately. The current CFO, Daphne Quimi, is set to retire at the end of the year.
August 21, 2023 | 11:18 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Simon Harford's appointment as CFO could bring new financial strategies to Amicus Therapeutics. Daphne Quimi's retirement may cause short-term uncertainty.
CFO changes can lead to shifts in financial strategy, which could impact the company's performance. However, the immediate impact of this news is uncertain. Daphne Quimi's retirement may cause some short-term uncertainty among investors.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100